Funding
Latest news, analysis, and updates on Funding from A47 News.
1139 stories in Business · Updated live
Anthropic Delays IPO Marketing to Mid-October 2026
Anthropic has postponed its IPO marketing timeline to mid-October 2026, with the prospectus now expected in late September. This shift follows a confidential filing with the U.S. Securities and Exchange Commission and is influenced by the company's preparations for a $15 billion revolving credit facility. The delay may strategically align with the U.S. midterm elections in November, potentially impacting investor sentiment and market conditions.
Nvidia Acquires Hugging Face for $12.9 Billion with Betaworks Securing $650 Million Stake
Nvidia announced the acquisition of Hugging Face for approximately $12.9 billion, marking a significant move into the open-source AI sector. This acquisition is driven by Nvidia's strategy to deepen its involvement in AI technologies and capitalize on Hugging Face's established platform. The long-term implication suggests a potential reshaping of the AI landscape, with increased focus on open-source solutions and substantial returns for early investors like Betaworks and A.Capital Ventures.
Novartis Phase 3 Trial of Pelacarsen Fails to Meet Cardiovascular Endpoint
On September 4, 2026, Novartis announced that its Phase 3 Lp(a)HORIZON trial of pelacarsen failed to meet the primary endpoint of reducing major cardiovascular events. The trial's failure is attributed to the drug's inability to lower the risk of cardiovascular death and other serious events despite successfully reducing Lp(a) levels in over 8,000 patients. This outcome may lead to a reevaluation of treatment strategies for patients with elevated lipoprotein(a) and could impact future research funding and drug development in cardiovascular therapies.
Gimlet Labs secures $300 million Series B funding at $3 billion valuation for AI inference platform
Gimlet Labs has raised $300 million in a Series B funding round, achieving a valuation of $3 billion. This funding, led by Andreessen Horowitz, is driven by the urgent need for more efficient AI inference solutions amid rising global demand. The long-term implication is a significant shift towards specialized AI infrastructure, potentially reshaping the landscape of AI deployment and efficiency.
Latest Stories
Anthropic Delays IPO Marketing to Mid-October 2026
Anthropic has postponed its IPO marketing timeline to mid-October 2026, with the prospectus now expected in late September. This shift follows a confidential filing with the U.S. Securities and Exchange Commission and is influenced by the company's preparations for a $15 billion revolving credit facility. The delay may strategically align with the U.S. midterm elections in November, potentially impacting investor sentiment and market conditions.
Nvidia Acquires Hugging Face for $12.9 Billion with Betaworks Securing $650 Million Stake
Nvidia announced the acquisition of Hugging Face for approximately $12.9 billion, marking a significant move into the open-source AI sector. This acquisition is driven by Nvidia's strategy to deepen its involvement in AI technologies and capitalize on Hugging Face's established platform. The long-term implication suggests a potential reshaping of the AI landscape, with increased focus on open-source solutions and substantial returns for early investors like Betaworks and A.Capital Ventures.
Novartis Phase 3 Trial of Pelacarsen Fails to Meet Cardiovascular Endpoint
On September 4, 2026, Novartis announced that its Phase 3 Lp(a)HORIZON trial of pelacarsen failed to meet the primary endpoint of reducing major cardiovascular events. The trial's failure is attributed to the drug's inability to lower the risk of cardiovascular death and other serious events despite successfully reducing Lp(a) levels in over 8,000 patients. This outcome may lead to a reevaluation of treatment strategies for patients with elevated lipoprotein(a) and could impact future research funding and drug development in cardiovascular therapies.
Gimlet Labs secures $300 million Series B funding at $3 billion valuation for AI inference platform
Gimlet Labs has raised $300 million in a Series B funding round, achieving a valuation of $3 billion. This funding, led by Andreessen Horowitz, is driven by the urgent need for more efficient AI inference solutions amid rising global demand. The long-term implication is a significant shift towards specialized AI infrastructure, potentially reshaping the landscape of AI deployment and efficiency.